ARTICLE | Company News
Forest Laboratories, Gruenenthal deal
January 3, 2011 8:00 AM UTC
Forest's Forest Healthcare B.V. subsidiary acquired from Gruenenthal its rights to antibiotic colistin and reacquired rights to Colobreathe colistimethate sodium to treat bacterial infections in pati...